The N-terminal domain of human urokinase receptor-contains two distinct regions critical for ligand recognitionPÖLLÄNEN, J. J.Blood. 1993, Vol 82, Num 9, pp 2719-2729, issn 0006-4971Article

Microplate immunocapture assay for plasminogen activators and their specific inhibitorsSTEPHENS, R; KIN-CHUEN LEUNG; POLLANEN, J et al.Journal of immunological methods. 1987, Vol 105, Num 2, pp 245-251, issn 0022-1759Article

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contactsPOLLANEN, J; HEDMAN, K; NIELSEN, L. S et al.The Journal of cell biology. 1988, Vol 106, Num 1, pp 87-95, issn 0021-9525Article

Directed plasminogen activation at the surface of normal and malignant cellsPOLLANEN, J; STEPHENS, R. W; VAHERI, A et al.Advances in cancer research. 1991, Vol 57, pp 273-328, issn 0065-230XArticle

Direct measurement of the ¹⁴N(p, γ)¹⁵O S factorRUNKLE, R. C; CHAMPAGNE, A. E; ANGULO, C et al.Physical review letters. 2005, Vol 94, Num 8, pp 082503.1-082503.4, issn 0031-9007Article

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cellsPOLLANEN, J; SAKSELA, O; SALONEN, E.-M et al.The Journal of cell biology. 1987, Vol 104, Num 4, pp 1085-1096, issn 0021-9525Article

Stimulation of cell surface plasminogen activation by heparin and related polyionic substancesSTEPHENS, R. W; PÖLLÄNEN, J; TAPIOVAARA, H et al.Seminars in thrombosis and hemostasis. 1991, Vol 17, Num 3, pp 201-209, issn 0094-6176Conference Paper

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptorOLSON, D; PÖLLÄNEN, J; HØYER-HANSEN, G et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 13, pp 9129-9133, issn 0021-9258Article

A low noise receiver at 22 GHz for the radioastron satelliteMALLAT, J; PIIRONEN, P; YLINEN, J et al.IGARSS 91 : international geoscience and remote sensing symposium. 1990, isbn 0-87942-675-6, 4Vol, vol. 4, 2111-2114Conference Paper

Biological treatment in rheumatic diseases: results from a longitudinal surveillance : adverse eventsKONTTINEN, L; HONKANEN, V; NORDSTROM, D. C et al.Rheumatology international (Berlin. Print). 2006, Vol 26, Num 10, pp 916-922, issn 0172-8172, 7 p.Article